Laura Magnano

15PUBLICATIONS
61CO-AUTHORS
Tumour immunologyHaematological tumoursPredictive and prognostic markersNutrigenomics and personalised nutritionRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 11, 2026
Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma and Tuberculosis: A Rare Association With Diagnostic and Therapeutic Challenges.

Amalia Del Val Talens, Olga Balague, Sonia Rodriguez

|May 02, 2024
Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target.

Cèlia Dobaño-López, Juan García Valero, Ferran Araujo-Ayala

|Oct 31, 2023
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma.

Núria Martínez-Cibrián, Valentín Ortiz-Maldonado, Marta Español-Rego

|Oct 19, 2022
Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome.

Ana Muntañola, Pablo Mozas, Santiago Mercadal

|Nov 30, 2021
The Prognostic Nutritional Index (PNI) is an independent predictor of overall survival in older patients with follicular lymphoma.

Pablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado

|Oct 11, 2021
Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma.

Ivan Dlouhy, Kennosuke Karube, Anna Enjuanes

Pageof 3

Frequent Collaborators

7 joint publications

Armando López-Guillermo

7 joint publications

Elías Campo

6 joint publications

Ferran Nadeu

6 joint publications

Pablo Mozas